Cellnovo Group S.A. | Ownership
Companies that own Cellnovo Group S.A.
Financière Arbevel SA
992,786
6.19%
0
2.91%
12/31/2017
Norges Bank Investment Management
680,851
4.24%
0
0%
12/31/2017
Apo Asset Management GmbH
622,150
3.88%
0
0.08%
07/31/2018
Sycomore Asset Management SA
161,444
1.01%
95,000
0.02%
12/30/2016
La Banque Postale Asset Management SA
153,100
0.95%
0
0%
06/29/2018
Aramea Asset Management AG
146,280
0.91%
146,280
0.12%
09/30/2017
Peacock Capital GmbH
40,000
0.25%
40,000
0.24%
09/30/2017
Etoile Gestion SA
33,786
0.21%
0
0%
01/31/2018
CM-CIC Asset Management SA
20,000
0.13%
13,000
0%
06/30/2017
Allianz Global Investors GmbH (France)
175
0%
175
0%
12/31/2015
| Address |
13, rue de Londres
Paris Ile-de-France 75009
France
|
|
Employees
|
- |
| Website |
http://www.cellnovo.com |
| Updated |
07/08/2019 |
| Cellnovo Group SA is a medical technology company, which specializes in diabetes. The company develops and markets the first mobile, connected, all-in-one diabetes management system that helps make life easier for patients. Its products portfolio includes system, switch, pump therapy, and patient stories. |
